Lombard Odier Asset Management Switzerland SA Sells 9,459 Shares of Xylem Inc. $XYL

Lombard Odier Asset Management Switzerland SA decreased its holdings in Xylem Inc. (NYSE:XYL) by 74.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,250 shares of the industrial products company’s stock after selling 9,459 shares during the period. Lombard Odier Asset Management Switzerland SA’s holdings in Xylem were worth $388,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. J. Stern & Co. LLP boosted its stake in Xylem by 12,326.6% during the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after buying an additional 45,082,435 shares during the period. Norges Bank purchased a new stake in shares of Xylem in the fourth quarter valued at $361,012,000. SEB Asset Management AB bought a new stake in shares of Xylem in the 1st quarter worth about $66,700,000. Balyasny Asset Management L.P. boosted its stake in shares of Xylem by 346.2% during the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock worth $105,160,000 after purchasing an additional 553,152 shares during the period. Finally, Adage Capital Partners GP L.L.C. purchased a new position in shares of Xylem during the 2nd quarter worth about $64,407,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Up 3.9%

Shares of NYSE XYL opened at $124.87 on Wednesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The firm has a market capitalization of $29.68 billion, a price-to-earnings ratio of 31.06, a PEG ratio of 1.71 and a beta of 1.03. The stock has a 50 day moving average price of $114.64 and a 200 day moving average price of $122.45. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.34 by $0.12. The company had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period last year, the business posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Sell-side analysts expect that Xylem Inc. will post 5.52 earnings per share for the current year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. Xylem’s dividend payout ratio (DPR) is 42.79%.

Analysts Set New Price Targets

Several analysts have issued reports on XYL shares. Citigroup decreased their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. JPMorgan Chase & Co. cut their target price on Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Weiss Ratings cut Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Oppenheimer reduced their price target on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Finally, UBS Group raised their price target on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and a consensus target price of $153.15.

Insider Activity

In related news, Director Jerome A. Peribere bought 1,210 shares of the stock in a transaction on Monday, May 4th. The stock was bought at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This trade represents a 54.22% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.32% of the company’s stock.

Trending Headlines about Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Adjusted second-quarter earnings were $1.46 per share, exceeding the $1.34 analyst consensus and rising from $1.26 a year earlier. Net income increased to $263 million from $226 million. Xylem Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Xylem raised its 2026 adjusted EPS guidance to $5.55-$5.70 from $5.35-$5.60, above the roughly $5.53 analyst estimate. Full-year revenue guidance was maintained at approximately $9.2 billion. Xylem raises annual profit forecast
• Positive Sentiment: Adjusted EBITDA margin expanded 150 basis points year over year to 23.3%, supported by productivity savings, price realization and favorable business mix. Orders surged 42% year over year on a reported basis, or 41% organically.
• Positive Sentiment: Management said AI infrastructure is increasing water-treatment and water-management demand across semiconductor manufacturing, power generation, mining, food and beverage, and life sciences. Xylem Reports Second Quarter 2026 Results
• Neutral Sentiment: Revenue totaled $2.336 billion, up about 1.5% year over year and broadly in line with expectations, indicating that the main upside came from profitability and orders rather than significant sales growth.
• Neutral Sentiment: Recent analyst price targets have a median of $158.50, suggesting potential upside, although institutional activity was mixed, with more reported position reductions than additions.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.